Home › Schizophrenia › Oklahoma › Oklahoma City
Schizophrenia clinical trials in Oklahoma City, OK
4 studies for Schizophrenia are looking for participants at sites in and around Oklahoma City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
RecruitingPhase 3
- Local Institution - 0047, Oklahoma City
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
RecruitingPhase 3
- Sooner Clinical Research, Oklahoma City
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
RecruitingObservational study
- The Rivus Wellness & Research Institute, Oklahoma City
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
RecruitingPhase 3Healthy volunteers welcome
- Reviva site, Oklahoma City
About Schizophrenia
Schizophrenia is a serious brain illness that can include hearing voices that aren't there and thinking others are trying to hurt them.
More about Schizophrenia on MedlinePlus
Schizophrenia trials in other cities
- Atlanta, GA22 studies
- Chicago, IL21 studies
- Little Rock, AR19 studies
- Hollywood, FL15 studies
- Boston, MA14 studies
- Houston, TX13 studies
- San Diego, CA13 studies
- Hialeah, FL13 studies
- New York City, NY13 studies
- Austin, TX13 studies
- Garden Grove, CA12 studies
- Germantown, MD11 studies
Other studies in Oklahoma City
- Non-Small Cell Lung Cancer28 studies
- Ovarian Cancer28 studies
- Endometrial Cancer25 studies
- Colorectal Cancer22 studies
- Prostate Cancer21 studies
- Lung Cancer19 studies
- Breast Cancer17 studies
- Metastatic Cancer15 studies
- Cancer (all types)14 studies
- Acute Myeloid Leukemia14 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Pancreatic Cancer11 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.